According to a 2024 article by the Columbia University Department of Psychiatry, semaglutides 2021 FDA approval came with wide recognition for its medical benefits and its notable side effect of weight loss. What resulted from that was a surge in its off-label use as a weight-loss aid, propelling the drug into the spotlight far beyond its original intent. Then, also in 2021, the FDA approved Wegovy for individuals who are obese or overweight with additional health challenges. Columbia University also notes the ethical concerns of drugs like Ozempic and Wegovy, particularly in their pricing
and trauma to the eye (Megbele 2012
Alongside compounded semaglutide and tirzepatide, they prescribe Sermorelin for growth-hormone support, NAD+ for energy and cellular repair, and tadalafil for sexual-health support all under one online medical evaluation
GLP-1s benefit women in a way that no one is talking about GLP-1s are racking up health wins beyond weight loss: They show promise for helping with heart disease, kidney disease, arthritis and sleep apnea, among other conditions
Check out the list at
Already Lillys $1B and Roches effort suggest an AI arms race in pharma R&D
